Niklas Engels

Niklas Engels

Auto-generated profile, based on publicly available information

Niklas Engels

Institute of Cellular and Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
HGHansjörg Götzke
Hansjörg Götzke
MKMarkus Kilisch
Markus Kilisch
MMMarkel Martínez-Carranza
Markel Martínez-Carranza
SSShama Sograte-Idrissi
Shama Sograte-Idrissi
ARABirami Rajavel
ABirami Rajavel
SFSteffen Frey
Steffen Frey
Specialized epitope tags are widely used for detecting, manipulating or purifying proteins, but often their versatility is limited. Here, we introduce the ALFA-tag, a rationally designed epitope tag that serves a remarkably broad spectrum of applications in life sciences while outperforming established tags like the HA-, FLAG®- or myc-tag. The ALFA-tag forms a small and stable α-helix that is functional irrespective of its position on the target protein in prokaryotic and eukaryotic hosts. We characterize a nanobody (NbALFA) binding ALFA-tagged proteins from native or fixed specimen with low picomolar affinity. It is ideally suited for super-resolution microscopy, immunoprecipitations and Western blotting, and also allows in vivo detection of proteins. We show the crystal structure of the complex that enabled us to design a nanobody mutant (NbALFAPE) that permits efficient one-step purifications of native ALFA-tagged proteins, complexes and even entire living cells using peptide elution under physiological conditions.

21 November 2014 in Nature Communications
Verified
Journal Article
Open access
NENiklas Engels
Niklas Engels
LKLars M. König
Lars M. König
WSWiebke Schulze
Wiebke Schulze
DRDaniel Radtke
Daniel Radtke
KVKanika Vanshylla
Kanika Vanshylla
JWJürgen Wienands
Jürgen Wienands
The vigorous response of IgG-switched memory B cells to recurring pathogens involves enhanced signalling from their B-cell antigen receptors (BCRs). However, the molecular signal amplification mechanisms of memory-type BCRs remained unclear. Here, we identify the immunoglobulin tail tyrosine (ITT) motif in the cytoplasmic segments of membrane-bound IgGs (mIgGs) as the principle signal amplification device of memory-type BCRs in higher vertebrates and decipher its signalling microanatomy. We show that different families of protein tyrosine kinases act upstream and downstream of the ITT. Spleen tyrosine kinase (Syk) activity is required for ITT phosphorylation followed by recruitment of the adaptor protein Grb2 into the mIgG-BCR signalosome. Grb2 in turn recruits Bruton’s tyrosine kinase (Btk) to amplify BCR-induced Ca2+ mobilization. This molecular interplay of kinases and adaptors increases the antigen sensitivity of memory-type BCRs, which provides a cell-intrinsic trigger mechanism for the rapid reactivation of IgG-switched memory B cells on antigen recall.

22 May 2023 in Journal of Autoimmunity
Verified
Journal Article
Open access
PHPierre Henschel
Pierre Henschel
SLSybille Landwehr-Kenzel
Sybille Landwehr-Kenzel
NENiklas Engels
Niklas Engels
ASAndrea Schienke
Andrea Schienke
JKJakob Kremer
Jakob Kremer
FNFatih Noyan
Fatih Noyan
The forkhead family transcription factor (FOXP3) is an essential regulator for the development of regulatory T cells (Tregs) and orchestrates both suppressive function and Treg lineage identity. Stable expression of FOXP3 enables Tregs to maintain immune homeostasis and prevent autoimmunity. However, under pro-inflammatory conditions, FOXP3 expression in Tregs can become unstable, leading to loss of suppressive function and conversion into pathogenic T effector cells. Therefore, the success of adoptive cell therapy with chimeric antigen receptor (CAR) Tregs is highly dependent on the stability of FOXP3 expression to ensure the safety of the cell product. To warrant the stable expression of FOXP3 in CAR-Treg products, we have developed an HLA-A2-specific CAR vector that co-expresses FOXP3. The transduction of isolated human Tregs with the FOXP3-CAR led to an increase in the safety and efficacy of the CAR-Treg product. In a hostile microenvironment, under pro-inflammatory and IL-2-deficient conditions, FOXP3-CAR-Tregs showed a stable expression of FOXP3 compared to Control-CAR-Tregs. Furthermore, additional exogenous expression of FOXP3 did not induce phenotypic alterations and dysfunctions such as cell exhaustion, loss of functional Treg characteristics or abnormal cytokine secretion. In a humanized mouse model, FOXP3-CAR-Tregs displayed an excellent ability to prevent allograft rejection. Furthermore, FOXP3-CAR-Tregs revealed coherent Treg niche-filling capabilities. Overexpression of FOXP3 in CAR-Tregs has thereby the potential to increase the efficacy and reliability of cellular products, promoting their clinical use in organ transplantation and autoimmune diseases.

18 February 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MCMaria Angela Gomes de Castro
Maria Angela Gomes de Castro
HWHanna Wildhagen
Hanna Wildhagen
SSShama Sograte-Idrissi
Shama Sograte-Idrissi
CHChristoffer Hitzing
Christoffer Hitzing
MBMascha Binder
Mascha Binder
FOFelipe Opazo
Felipe Opazo
Stimulation of the B cell antigen receptor (BCR) triggers signaling pathways that promote the differentiation of B cells into plasma cells. Despite the pivotal function of BCR in B cell activation, the organization of the BCR on the surface of resting and antigen-activated B cells remains unclear. Here we show, using STED super-resolution microscopy, that IgM-containing BCRs exist predominantly as monomers and dimers in the plasma membrane of resting B cells, but form higher oligomeric clusters upon stimulation. By contrast, a chronic lymphocytic leukemia-derived BCR forms dimers and oligomers in the absence of a stimulus, but a single amino acid exchange reverts its organization to monomers in unstimulated B cells. Our super-resolution microscopy approach for quantitatively analyzing cell surface proteins may thus help reveal the nanoscale organization of immunoreceptors in various cell types.

17 April 2018 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
NENiklas Engels
Niklas Engels
JWJürgen Wienands
Jürgen Wienands

13 October 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJohannes Lutz
Johannes Lutz
KDKai Dittmann
Kai Dittmann
MBMichael R Bösl
Michael R Bösl
TWThomas H Winkler
Thomas H Winkler
JWJürgen Wienands
Jürgen Wienands
NENiklas Engels
Niklas Engels
Secondary antibody responses are marked by faster kinetics, improved antibody affinity and a switch from IgM to other immunoglobulin isotypes, most notably IgG, compared with primary responses. These changes protect from reinfection and represent the principle of most vaccination strategies. Yet, the molecular mechanisms that underlie B-cell memory responses are unclear. Here we show, by inactivating the immunoglobulin tail tyrosine (ITT) signalling motif of membrane-bound IgG1 in the mouse, that the ITT facilitates maintenance and reactivation of IgG-switched memory B cells in vivo. The ITT motif equips IgG-switched cells with enhanced BCR signalling capacity, which supports their competitiveness in secondary immune reactions and drives the formation of IgG-secreting plasma cells even in the absence of T-cell help. Our results demonstrate that ITT signalling promotes the vigorous production of IgG antibodies and thus provide a molecular basis for humoral immunological memory.